Zobrazeno 1 - 10
of 19
pro vyhledávání: '"K M, Attie"'
Autor:
K M Attie
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 81:1683-1685
Autor:
S. F. Kemp, P. J. Fielder, K. M. Attie, S. L. Blethen, E. O. Reiter, K. M. Ford, M. Marian, L. N. Dao, H. J. Lee, P. Saenger
Publikováno v:
The Journal of clinical endocrinology and metabolism. 89(7)
Long-term GH replacement therapy is indicated for children with growth failure due to GH deficiency (GHD). We evaluated the feasibility of administering a long-acting GH preparation [Nutropin Depot (somatropin, rDNA origin) for injectable suspension]
Autor:
K M, Attie
Publikováno v:
Journal of pediatric endocrinologymetabolism : JPEM. 13
Growth hormone (GH) plays an important role in longitudinal bone growth in childhood, accrual of peak bone mass, and bone preservation in adults. GH deficiency (GHD) is associated with reduced bone turnover and decreased bone mineral density (BMD), e
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(10)
GH production rates markedly increase during human puberty, mostly as an amplitude-modulated phenomenon. However, GH-deficient children have been dosed on a standard per kg BW basis similar to prepubertal children. This randomized study was designed
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(7)
Clinical trials of recombinant human GH therapy in Turner syndrome that began more than a decade ago show that GH accelerates the linear growth rate. Several studies indicate that final height is also improved, although the magnitude of the increase
Publikováno v:
The New England journal of medicine. 340(7)
Short-term administration of growth hormone to children with idiopathic short stature results in increases in growth rate and standard-deviation scores for height. However, the effect of long-term growth hormone therapy on adult height in these child
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(9)
In a multicenter study the metabolic effects of 5 yr of GH therapy in children with idiopathic short stature were evaluated. Patients received 0.3 mg/kg.week recombinant human GH. Of the 121 patients who entered the study, data for 62 were analyzed a
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(8)
Growth failure is common during long term treatment with glucocorticoids (GC) due to blunting of GH release, insulin-like growth factor I (IGF-I) bioactivity, and collagen synthesis. These effects could theoretically be reversed with GH therapy. The
Publikováno v:
Pediatrics. 102(2 Pt 3)
To evaluate growth rate and adult height with recombinant growth hormone (GH) treatment in girls with Turner syndrome (TS) and predictors of their growth response.Data on girls with TS who were treated with GH in the National Cooperative Growth Study
Autor:
K M Attie, A J Johanson, C P Mahoney, S Burstein, Ron G. Rosenfeld, W V Moore, R W Gotlin, P Saenger, B M Lippe, J Frane, S Chernausek, J A Brasel, J Kuntze, J F Cara
Publikováno v:
The Journal of pediatrics. 132(2)
Objective: To carry out a multicenter, prospective, randomized trial of human growth hormone (GH), alone or in combination with oxandrolone (OX), in patients with Turner's syndrome (TS). Methods: In an initial phase lasting 12 to 24 months, 70 girls